Cargando…
Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects
The goals of Epilepsy Benchmark Area III involve identifying areas that are ripe for progress in terms of controlling seizures and patient symptoms in light of the most recent advances in both basic and clinical research. These goals were developed with an emphasis on potential new therapeutic strat...
Autores principales: | Traynelis, Stephen F., Dlugos, Dennis, Henshall, David, Mefford, Heather C., Rogawski, Michael A., Staley, Kevin J., Dacks, Penny A., Whittemore, Vicky, Poduri, Annapurna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031805/ https://www.ncbi.nlm.nih.gov/pubmed/31965829 http://dx.doi.org/10.1177/1535759719895279 |
Ejemplares similares
-
Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions
por: Chang, Bernard S., et al.
Publicado: (2020) -
Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression
por: Binder, Devin K., et al.
Publicado: (2020) -
The Benchmarks: Progress and Emerging Priorities in Epilepsy Research
por: Poduri, Annapurna, et al.
Publicado: (2019) -
Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span
por: Jones, Jana E., et al.
Publicado: (2020) -
The 2021 Epilepsy Research Benchmarks—Respecting Core Principles,
Reflecting Evolving Community Priorities
por: Marsh, Eric D., et al.
Publicado: (2021)